185 related articles for article (PubMed ID: 9169997)
1. Effect of high-performance liquid chromatography on plasma angiotensin II measurements in treated and untreated normotensive and hypertensive patients.
Bragat AC; Blumenfeld J; Sealey JE
J Hypertens; 1997 May; 15(5):459-65. PubMed ID: 9169997
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
[TBL] [Abstract][Full Text] [Related]
3. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
4. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.
Goldberg MR; Tanaka W; Barchowsky A; Bradstreet TE; McCrea J; Lo MW; McWilliams EJ; Bjornsson TD
Hypertension; 1993 May; 21(5):704-13. PubMed ID: 8491505
[TBL] [Abstract][Full Text] [Related]
5. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
6. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
Herlitz H; Palmgren E; Widgren B; Aurell M
Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242
[TBL] [Abstract][Full Text] [Related]
7. The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.
Simões E Silva AC; Diniz JS; Regueira Filho A; Santos RA
J Pediatr; 2004 Jul; 145(1):93-8. PubMed ID: 15238914
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients.
Püchler K; Nussberger J; Laeis P; Witte PU; Brunner HR
J Hypertens; 1997 Dec; 15(12 Pt 2):1809-12. PubMed ID: 9488244
[TBL] [Abstract][Full Text] [Related]
9. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II.
Gahnem F; Camargo MJ; von Lutterotti N; Laragh JH; Sealey JE
J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857
[TBL] [Abstract][Full Text] [Related]
10. Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II type 1 receptor antagonist and their plasma levels in patients with chronic renal failure.
Shibasaki Y; Mori Y; Tsutumi Y; Masaki H; Sakamoto K; Murasawa S; Maruyama K; Moriguchi Y; Tanaka Y; Iwasaka T; Inada M; Matsubara H
Clin Nephrol; 1999 Feb; 51(2):83-91. PubMed ID: 10069643
[TBL] [Abstract][Full Text] [Related]
11. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
12. Role of the renin-angiotensin system in hypertension in the elderly.
Nagano M; Higaki J; Mikami H; Ogihara T
Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
[TBL] [Abstract][Full Text] [Related]
14. Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatment.
Willemsen JM; Rabelink TJ; Boer P; Gaillard CA
J Hum Hypertens; 2004 Dec; 18(12):857-63. PubMed ID: 15361886
[TBL] [Abstract][Full Text] [Related]
15. Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease.
Simões e Silva AC; Diniz JS; Pereira RM; Pinheiro SV; Santos RA
Pediatr Res; 2006 Dec; 60(6):734-9. PubMed ID: 17065573
[TBL] [Abstract][Full Text] [Related]
16. Newly developed radioimmunoassay for Human Angiotensin-(1-12) measurements in plasma and urine.
Ahmad S; Punzi HA; Wright KN; Groban L; Ferrario CM
Mol Cell Endocrinol; 2021 Jun; 529():111256. PubMed ID: 33798634
[TBL] [Abstract][Full Text] [Related]
17. [Association of aldosterone synthase gene -344T/C polymorphism with plasma aldosterone and angiotensin II concentration in hypertensive patients].
Hu BC; Chu SL; Wang JG; Wang ZH; Wang GL; Gao PJ; Zhu DL
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1144-7. PubMed ID: 16796847
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
Umeda M; Ichikawa S; Kanda T; Sumino H; Kobayashi I
Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230
[TBL] [Abstract][Full Text] [Related]
19. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
[TBL] [Abstract][Full Text] [Related]
20. Blunted suppression of plasma renin activity in diabetes.
Gordon MS; Price DA; Hollenberg NK
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):252-6. PubMed ID: 11881033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]